PIERIS PHARMACEUTICALS, INC. - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 13, 2020

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex322.htm
EX-32.1 - EXHIBIT 32.1 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex321.htm
EX-31.2 - EXHIBIT 31.2 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex312.htm
EX-31.1 - EXHIBIT 31.1 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex311.htm
EX-23.1 - EXHIBIT 23.1 - PIERIS PHARMACEUTICALS, INC.pirs12-31x2019ex231.htm
EX-14.1 - EXHIBIT 14.1 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex141.htm
EX-10.32 - EXHIBIT 10.32 - PIERIS PHARMACEUTICALS, INC.pirs12312019exh1032.htm
EX-10.31 - EXHIBIT 10.31 - PIERIS PHARMACEUTICALS, INC.pirs12312019exh1031.htm
EX-10.26 - EXHIBIT 10.26 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex1026.htm
EX-10.25 - EXHIBIT 10.25 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex1025.htm
EX-10.16 - EXHIBIT 10.16 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex1016.htm
EX-4.3 - EXHIBIT 4.3 - PIERIS PHARMACEUTICALS, INC.pirs12312019ex-43.htm
10-K - 10-K - PIERIS PHARMACEUTICALS, INC.pirs12-31x201910xk.htm


Exhibit 21.1
Subsidiaries
 
Entity
  
Jurisdiction of Organization
Pieris Pharmaceuticals GmbH
  
Germany
Pieris Australia Pty Limited
  
Australia
Pieris Pharmaceuticals Securities Corporation
 
Massachusetts


PIERIS PHARMACEUTICALS, INC. Reports